Invention Grant
- Patent Title: Inhibitors of lysine specific demethylase-1
- Patent Title (中): 赖氨酸特异性脱甲基酶抑制剂-1
-
Application No.: US14701304Application Date: 2015-04-30
-
Publication No.: US09255097B2Publication Date: 2016-02-09
- Inventor: Young K. Chen , Toufike Kanouni , Stephen W. Kaldor , Jeffrey Alan Stafford , James Marvin Veal
- Applicant: Quanticel Pharmaceuticals, Inc.
- Applicant Address: US CA San Diego
- Assignee: QUANTICEL PHARMACEUTICALS, INC.
- Current Assignee: QUANTICEL PHARMACEUTICALS, INC.
- Current Assignee Address: US CA San Diego
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D401/14 ; A61K31/513 ; C07D471/10 ; C07D405/14 ; C07D401/12 ; C07D403/04 ; C07D239/36 ; C07D403/14 ; C07B59/00
Abstract:
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of lysine specific demethylase-1. Furthermore, the subject compounds and compositions are useful for the treatment of cancer.
Public/Granted literature
- US20150315187A1 INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 Public/Granted day:2015-11-05
Information query
